The ultimate goal of cancer immunotherapy is the activation of T-cell responses specific for tumor-associated antigens capable of destroying tumor cells.
Challenges in the design of reliable immuno-oncology mouse models to inform drug development
Mondanelli, Giada;Volpi, Claudia;Orabona, Ciriana;Grohmann, Ursula
2017
Abstract
The ultimate goal of cancer immunotherapy is the activation of T-cell responses specific for tumor-associated antigens capable of destroying tumor cells.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
